1.83
-0.28(-13.27%)
Currency In USD
| Previous Close | 2.11 |
| Open | 2.12 |
| Day High | 2.14 |
| Day Low | 1.81 |
| 52-Week High | 2.27 |
| 52-Week Low | 0.4 |
| Volume | 771,232 |
| Average Volume | 960,806 |
| Market Cap | 98M |
| PE | -0.85 |
| EPS | -2.16 |
| Moving Average 50 Days | 1.1 |
| Moving Average 200 Days | 0.92 |
| Change | -0.28 |
If you invested $1000 in ALX Oncology Holdings Inc. (ALXO) since IPO date, it would be worth $61 as of October 08, 2025 at a share price of $1.83. Whereas If you bought $1000 worth of ALX Oncology Holdings Inc. (ALXO) shares 3 years ago, it would be worth $185.22 as of October 08, 2025 at a share price of $1.83.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
GlobeNewswire Inc.
Oct 03, 2025 1:05 PM GMT
Company will share data demonstrating CD47 overexpression as key predictive biomarker for response with the Company’s lead candidate, evorpacept, in HER2+ gastric cancer SOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Ho
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
GlobeNewswire Inc.
Sep 12, 2025 12:30 PM GMT
Dr. Barbara Klencke is an accomplished clinical leader with a distinguished track record in oncology drug development who currently serves on the Company’s Board of Directors and will step down from the Board to join ALX as Interim Chief Medical Offi
ALX Oncology to Participate in Upcoming Investor Conferences in September
GlobeNewswire Inc.
Aug 29, 2025 4:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and